Factor VIII related antigen as an endothelial cell marker in benign and malignant diseases

1981 ◽  
Vol 391 (2) ◽  
pp. 217-225 ◽  
Author(s):  
Maxwell Sehested ◽  
Klaus Hou-Jensen
1988 ◽  
Vol 25 (4) ◽  
pp. 251-255 ◽  
Author(s):  
B. R. von Beust ◽  
M. M. Suter ◽  
B. A. Summers

Canine vascular tumors (47 hemangiomas, 36 hemangiosarcomas) were investigated for the endothelial cell marker factor VIII-related antigen (F VIII RAg). The primary antibody was a commercial rabbit anti-human (r/h) F VIII RAg antiserum. All (100%) hemangiomas and 32 (89%) of 36 hemangiosarcomas stained for F VIII RAg. One hemangiosarcoma (3%) was negative, and three tumors (8%) were equivocal in staining. Rarely, the interpretation of stained immature endothelial cells was difficult. The r/h F VIII RAg antibody was a positive marker of normal, reactive, and neoplastic endothelial cells in the dog.


1992 ◽  
Vol 6 (3) ◽  
pp. 223-229
Author(s):  
Anna Porwit ◽  
Birger Christensson ◽  
A. Karolina Palucka ◽  
Charlotta Wickman ◽  
Anna-Lena Petrén ◽  
...  

2014 ◽  
Vol 105 (12) ◽  
pp. 1533-1540 ◽  
Author(s):  
Mohammad T. Alam ◽  
Hiroko Nagao‐Kitamoto ◽  
Noritaka Ohga ◽  
Kosuke Akiyama ◽  
Nako Maishi ◽  
...  

Blood ◽  
2013 ◽  
Vol 121 (7) ◽  
pp. 1229-1237 ◽  
Author(s):  
Natalia Platonova ◽  
Geraldine Miquel ◽  
Birgit Regenfuss ◽  
Said Taouji ◽  
Claus Cursiefen ◽  
...  

Key Points FGF2 is able to directly interact with LYVE-1 and glycosylation of LYVE-1 is important for the interaction with FGF2. LYVE-1 inhibits FGF2-dependent lymphangiogenesis and FGF2 modulates LYVE-1's endogenous expression and reverses the effect of TNFβ.


Sign in / Sign up

Export Citation Format

Share Document